<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
	<id>tag:old.nabble.com,2006:forum-11541</id>
	<title>Nabble - Bio.net - Hiv-biol</title>
	<updated>2008-04-15T14:58:39Z</updated>
	<link rel="self" type="application/atom+xml" href="http://old.nabble.com/Bio.net---Hiv-biol-f11541.xml" />
	<link rel="alternate" type="text/html" href="http://old.nabble.com/Bio.net---Hiv-biol-f11541.html" />
	<subtitle type="html">HIV-MOLECULAR-BIOLOGY/bionet.molbio.hiv</subtitle>
	
<entry>
	<id>tag:old.nabble.com,2006:post-16729881</id>
	<title>VIZIER / SPINE2 Workshop on Structural Virology</title>
	<published>2008-04-15T14:58:39Z</published>
	<updated>2008-04-15T14:58:39Z</updated>
	<author>
		<name>Paul Tucker-2</name>
	</author>
	<content type="html">&lt;html&gt;&lt;body style=&quot;word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; &quot;&gt;&lt;div style=&quot;word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; &quot;&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;Dear Virologist,&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Registrations are now being accepted for the&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*VIZIER / SPINE2 Workshop on Structural Virology*&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;taking place from 14th - 16th July  2008, in Vienna, Austria&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;This workshop will cover recent advances in our understanding of viral &lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;entry, assembly, replication and pathogenesis principally, but not &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;exclusively, based upon information derived from structural studies. The &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;planned sessions are on viral assembly, double-stranded RNA viruses, the &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;flavivirus replication machinery, the coronavirus replication machinery, &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;virus/host interactions including aspects of viral entry, negative &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;strand RNA viruses and viruses of prokaryotes and archea.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;In addition to the invited speakers, oral presentations will be selected &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;from the submitted abstracts. The sessions are not exclusive and any &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;topic relevant to the structural biology of viruses will be considered &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;for a poster or oral presentation. For this reason early registration &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;and abstract submission is strongly encouraged.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;The workshop is part of the training and dissemination activities of the &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Vizier and Spine2Complexes projects. The Department of Biomolecular &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Structural Chemistry, Max F. Perutz Labs at University of Vienna is a &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Training and Dissemination Centre for the EU 6th Framework VIZIER &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;project (http://www.vizier-europe.org &amp;lt;&lt;a href=&quot;http://www.vizier-europe.org/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.vizier-europe.org/&lt;/a&gt;&gt;).&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;INVITED SPEAKERS INCLUDE*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Virus assembly*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Alasdair Steven (NIAMS)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Double-stranded RNA viruses*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Jon Grimes (Oxford), B.V.V. Prasad (Baylor College of Medicine)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Flavivirus replication machinery*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Martino Bolognesi (Milano), Bruno Canard (Marseilles), Hongmin Li (NY &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;State Dept. of Health)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Coronavirus replication machinery*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Rolf Hilgenfeld (Lubeck)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Viral entry/Virus host interactions*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Felix Rey (Institute Pasteur), Katsumi Maenaka (Fukuoka), Winfried &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Weissenhorn (Grenoble)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Negative strand RNA viruses*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Rob Ruigrok (IVMS Grenoble), Stephen Graham (Oxford), Zihe Rao (Tsinghua)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;*Viruses infecting bacteria and archea*:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Herman van Tilbeurgh (Orsay), Denis Bamford (Helsinki)&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;The number of participants is limited to 100, the applicants will be &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;accepted on a first-come first-served basis.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;More information on this Workshop (all details, description, &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;registration) are available at:&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;&lt;a href=&quot;http://www.projects.mfpl.ac.at/structural-virology/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.projects.mfpl.ac.at/structural-virology/&lt;/a&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;******Deadline for abstract submission and registration is 15th June 2008.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;We strongly encourage you to register soon, even if you do not have all&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;registration details in hand, and BOOK a hotel ASAP! Vienna is a busy &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;city in summer.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;You can complete/confirm your registration afterwards, until the &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;registration deadline June 15th, 2008, using the link that will be sent to you via &lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;e-mail.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; font: normal normal normal 12px/normal Helvetica; min-height: 14px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;font face=&quot;Helvetica&quot; size=&quot;3&quot; style=&quot;font: normal normal normal 12px/normal Helvetica; &quot;&gt;Please feel free to forward this email to anyone you think might be interested.&lt;/font&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space: pre; &quot;&gt;		&lt;/span&gt;Paul Tucker&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div style=&quot;margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; &quot;&gt;&lt;br&gt;&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;br&gt;&lt;br&gt;&lt;div&gt;&lt;div&gt;************************************************************************&lt;/div&gt;&lt;div&gt;                                          Dr. Paul A. Tucker                                           &lt;/div&gt;&lt;div&gt;                                                                                                                      &lt;/div&gt;&lt;div&gt;                                              Group Leader                                              &lt;/div&gt;&lt;div&gt;                                                                                                                      &lt;/div&gt;&lt;div&gt;  EMBL Hamburg Outstation        Tel:   +49 40 89902129                &lt;/div&gt;&lt;div&gt;  c/o DESY, Notkestrasse 85        FAX:   +49 40 89902149               &lt;/div&gt;&lt;div&gt;  D22603 Hamburg                        Email  &lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=16729881&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;tucker@...&lt;/a&gt;     &lt;/div&gt;&lt;div&gt;  Germany                                                                                                   &lt;/div&gt;&lt;div&gt;                                                                                                                      &lt;/div&gt;&lt;div&gt;************************************************************************&lt;/div&gt;&lt;div&gt;&lt;br&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;/body&gt;&lt;/html&gt;&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=16729881&amp;i=1&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/VIZIER---SPINE2-Workshop-on-Structural-Virology-tp16729881p16729881.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-5307114</id>
	<title>4 One Million Dollar. The Experiment begins...http://4onemillion.blogspot.com/</title>
	<published>2006-07-13T06:14:05Z</published>
	<updated>2006-07-13T06:14:05Z</updated>
	<author>
		<name>http:&quot;//4onemillion.blogspot.com/&quot;&lt;4onemilliondollar</name>
	</author>
	<content type="html">&lt;HTML&gt;
&lt;HEAD&gt;
&lt;META NAME=&quot;GENERATOR&quot; Content=&quot;Microsoft DHTML Editing Control&quot;&gt;
&lt;TITLE&gt;&lt;/TITLE&gt;
&lt;/HEAD&gt;
&lt;BODY&gt;
&lt;P&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=6&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;  &lt;/STRONG&gt;&lt;STRONG&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT color=#ff0000 size=5&gt;Take 
a look....&lt;/FONT&gt;  &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT color=#ff0000 size=5&gt;The 
Experiment.......................................&lt;/FONT&gt; 
&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;&lt;FONT size=6&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;/BODY&gt;
&lt;/HTML&gt;






&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=5307114&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/4-One-Million-Dollar.-The-Experiment-begins...http%3A--4onemillion.blogspot.com--tp5307114p5307114.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-5302077</id>
	<title>Kleinanzeigenmarkt Korou Bundesweit und kostenlos Korou Kleinanzeigen</title>
	<published>2006-07-12T22:46:43Z</published>
	<updated>2006-07-12T22:46:43Z</updated>
	<author>
		<name>ashi-3</name>
	</author>
	<content type="html">&lt;HTML&gt;
&lt;HEAD&gt;
&lt;META NAME=&quot;GENERATOR&quot; Content=&quot;Microsoft DHTML Editing Control&quot;&gt;
&lt;TITLE&gt;&lt;/TITLE&gt;
&lt;/HEAD&gt;
&lt;BODY&gt;
&lt;P&gt;Der clevere Kleinanzeigenmarkt.Korou.de Jetzt kostenlos 
in Deutschlands Nr.1 der Kleinanzeigenmärkte Inserieren! Bundesweit und 
kostenlos.Korou,Korou&lt;/P&gt;
&lt;P&gt;chat,kleinanzeigen,kostenlos,umsonst,inserat,bundesweit,urlaub,computer,ebay,google,markt,neu,gebraucht,&lt;/P&gt;
&lt;P&gt;kleinanzeigenmarkt,autos,immobilien,shopping,shop,gewerbe,privat,mp3,korou,test,gebrauchtwagen,kijiji,vivastreet,&lt;/P&gt;
&lt;P&gt;quoka&lt;/P&gt;
&lt;/BODY&gt;
&lt;/HTML&gt;


&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=5302077&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/Kleinanzeigenmarkt-Korou-Bundesweit-und-kostenlos-Korou-Kleinanzeigen-tp5302077p5302077.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-5288272</id>
	<title>4 One Million Dollar. The Experiment begins...http://4onemillion.blogspot.com/</title>
	<published>2006-07-12T06:47:22Z</published>
	<updated>2006-07-12T06:47:22Z</updated>
	<author>
		<name>http:&quot;//4onemillion.blogspot.com/&quot;&lt;4onemilliondollar</name>
	</author>
	<content type="html">&lt;HTML&gt;
&lt;HEAD&gt;
&lt;META NAME=&quot;GENERATOR&quot; Content=&quot;Microsoft DHTML Editing Control&quot;&gt;
&lt;TITLE&gt;&lt;/TITLE&gt;
&lt;/HEAD&gt;
&lt;BODY&gt;
&lt;P&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=6&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt;  &lt;/STRONG&gt;&lt;STRONG&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT color=#ff0000 size=5&gt;Take 
a look....&lt;/FONT&gt;  &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT color=#ff0000 size=5&gt;The 
Experiment.......................................&lt;/FONT&gt; 
&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;&lt;FONT size=6&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;chat,money,business,mp3,kostenlos,geld,dollar,rich,ebay,google,cars,auto,house,web,microsoft,windows,linux,computer,blog,blogger&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;/BODY&gt;
&lt;/HTML&gt;






&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=5288272&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/4-One-Million-Dollar.-The-Experiment-begins...http%3A--4onemillion.blogspot.com--tp5288272p5288272.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-5285102</id>
	<title>4 One Million Dollar. The Experiment begins...http://4onemillion.blogspot.com/</title>
	<published>2006-07-12T02:36:16Z</published>
	<updated>2006-07-12T02:36:16Z</updated>
	<author>
		<name>http:&quot;//4onemillion.blogspot.com/&quot;&lt;4onemilliondollar</name>
	</author>
	<content type="html">&lt;HTML&gt;
&lt;HEAD&gt;
&lt;META NAME=&quot;GENERATOR&quot; Content=&quot;Microsoft DHTML Editing Control&quot;&gt;
&lt;TITLE&gt;&lt;/TITLE&gt;
&lt;/HEAD&gt;
&lt;BODY&gt;
&lt;P&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;&lt;STRONG&gt;&lt;FONT size=6&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Take a look....&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;The 
Experiment.......................................&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href=&quot;http://4onemillion.blogspot.com/&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;&lt;FONT size=6&gt;http://4onemillion.blogspot.com/&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;
&lt;/BODY&gt;
&lt;/HTML&gt;


&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=5285102&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/4-One-Million-Dollar.-The-Experiment-begins...http%3A--4onemillion.blogspot.com--tp5285102p5285102.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-5042184</id>
	<title>korou bundesweiter kleinanzeigenmarkt kostenlos korou</title>
	<published>2006-06-26T00:30:50Z</published>
	<updated>2006-06-26T00:30:50Z</updated>
	<author>
		<name>webadmins</name>
	</author>
	<content type="html">&lt;HTML&gt;
&lt;HEAD&gt;
&lt;META NAME=&quot;GENERATOR&quot; Content=&quot;Microsoft DHTML Editing Control&quot;&gt;
&lt;TITLE&gt;&lt;/TITLE&gt;
&lt;/HEAD&gt;
&lt;BODY&gt;
&lt;P&gt;Bundesweiter Kleinanzeigenmarkt korou&amp;nbsp;fuer Gewerbe 
und privat&amp;nbsp;kostenlos,inserieren&lt;/P&gt;
&lt;P&gt;bundesweit,umsonst,korou,chat,auto,markt,inserat,jobs,kleinanzeigen,korou,korou,korou&lt;/P&gt;
&lt;P&gt;Bundesweiter kleinanzeigenmarkt korou,korou,korou&lt;/P&gt;
&lt;/BODY&gt;
&lt;/HTML&gt;





&lt;br /&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=5042184&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/korou-bundesweiter-kleinanzeigenmarkt-kostenlos-korou-tp5042184p5042184.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-3302681</id>
	<title>CFP: IAENG International Conference on Mathematical, Statistical and Computer Methods in HIV/AIDS</title>
	<published>2006-03-08T07:27:11Z</published>
	<updated>2006-03-08T07:27:11Z</updated>
	<author>
		<name>imecs__2006</name>
	</author>
	<content type="html">Call for Papers from:
&lt;br&gt;International Association of Engineers (&lt;a href=&quot;http://www.iaeng.org&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.iaeng.org&lt;/a&gt;)
&lt;br&gt;Journal Engineering Letters (&lt;a href=&quot;http://www.engineeringletters.com&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.engineeringletters.com&lt;/a&gt;)
&lt;br&gt;&lt;br&gt;The 2006 IAENG International Conference on Mathematical, Statistical
&lt;br&gt;and Computer Methods in HIV/AIDS 2006
&lt;br&gt;&lt;br&gt;(Part of The International MultiConference of Engineers and Computer
&lt;br&gt;Scientists IMECS 2006)
&lt;br&gt;&lt;br&gt;IMECS 2006: 20-22 June, 2006, Hong Kong
&lt;br&gt;&lt;a href=&quot;http://www.iaeng.org/IMECS2006/ICMHA2006.html&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.iaeng.org/IMECS2006/ICMHA2006.html&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;Considering that a large number of people in any community do not know
&lt;br&gt;that they are HIV positive, and consequently, that the HIV prevalence
&lt;br&gt;estimates in any country are usually unreliable, the purpose of this
&lt;br&gt;Conference is to bring together researchers from all over the world to
&lt;br&gt;discuss methods for accurate estimates and future predictions of
&lt;br&gt;HIV/AIDS incidence and prevalence in different parts of the world.
&lt;br&gt;While papers (both research papers and discussion papers) from all
&lt;br&gt;parts of the world are very welcome, those discussing hiv prevalence in
&lt;br&gt;Africa, all parts of Asia, and in Eastern Europe and in Russia should
&lt;br&gt;add a very desirable breadth to the conference. All papers discussing
&lt;br&gt;these issues through Mathematical, Statistical, Computer, Survey and
&lt;br&gt;any other methods will be welcome.
&lt;br&gt;&lt;br&gt;The ICMHA'06 conference is held as part of the International
&lt;br&gt;MultiConference of Engineers and Computer Scientists 2006. The IMECS
&lt;br&gt;2006 is organized by the International Association of Engineers
&lt;br&gt;(IAENG), and serves as good platforms for the engineering community
&lt;br&gt;members to meet with each other and to exchange ideas. Extended version
&lt;br&gt;of the papers under this workshop can be included in the special issue
&lt;br&gt;of our journal Engineering Letters. And, further extended version can
&lt;br&gt;also be included in a book called &amp;quot;Current Trends in Mathematical,
&lt;br&gt;Statistical and Computer Methods in HIV/AIDS 2006&amp;quot; to be published by
&lt;br&gt;IAENG.
&lt;br&gt;&lt;br&gt;The IMECS 2006 multiconference has the focus on the frontier topics in
&lt;br&gt;the theoretical and applied engineering and computer science subjects.
&lt;br&gt;It consists of 14 workshops (see the details at IMECS website:
&lt;br&gt;www.iaeng.org/IMECS2006). The multiconference serves as good platforms
&lt;br&gt;for the engineering community members of different disciplines to meet
&lt;br&gt;with each other and to exchange ideas. The current conference committee
&lt;br&gt;of the IMECS 2006 includes over 150 workshop co-chairs and committee
&lt;br&gt;members of mainly research center heads, department heads, professors,
&lt;br&gt;research scientists from over 20 countries, while a few of the
&lt;br&gt;committee members are also experienced software development directors
&lt;br&gt;and engineers.
&lt;br&gt;&lt;br&gt;All submitted papers will be under peer review and accepted papers will
&lt;br&gt;be published in the conference proceeding (ISBN: 988-98671-3-3). The
&lt;br&gt;abstracts will be indexed and available at major academic databases.
&lt;br&gt;The Technology Research Databases (TRD) of CSA (Cambridge Scientific
&lt;br&gt;Abstracts), DBLP and Computer Science Bibliographies have promised to
&lt;br&gt;index the print proceeding in advance of its publication. And after the
&lt;br&gt;publication of the proceeding, print copies will also be sent to
&lt;br&gt;databases like IEE INSPEC, Engineering Index (EI) and ISI Thomson
&lt;br&gt;Scientific for indexing. The accepted papers will also be considered
&lt;br&gt;for publication in the special issues of the journal Engineering
&lt;br&gt;Letters. Some participants may also be invited to submit extended
&lt;br&gt;version of their conference papers for considering as book chapters
&lt;br&gt;(soon after the conference).
&lt;br&gt;&lt;br&gt;&lt;br&gt;=========
&lt;br&gt;Submission:
&lt;br&gt;&lt;br&gt;Prospective authors are invited to submit their draft paper in abstract
&lt;br&gt;format (one page) or in full paper format to &lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=3302681&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;imecs@...&lt;/a&gt; by 12
&lt;br&gt;March, 2006. The submitted file can be in MS Word format, PS format, or
&lt;br&gt;PDF formats.
&lt;br&gt;&lt;br&gt;The first page of the draft paper should include:
&lt;br&gt;&lt;br&gt;· Title of the paper;
&lt;br&gt;· Name, affiliation and e-mail address for each author;
&lt;br&gt;· A maximum of 5 keywords of the paper;
&lt;br&gt;&lt;br&gt;Also, the name of the workshop session that the paper is being
&lt;br&gt;submitted to should be stated in the email.
&lt;br&gt;&lt;br&gt;&lt;br&gt;=============
&lt;br&gt;Important Dates:
&lt;br&gt;&lt;br&gt;Proposals for special conference sessions and tutorials deadline: 30
&lt;br&gt;December, 2005
&lt;br&gt;Draft Manuscript / Abstract submission deadline: 12 March, 2006
&lt;br&gt;Camera-Ready papers &amp; Pre-registration due: 2 April, 2006
&lt;br&gt;IMECS 2006: 20-22 June, 2006
&lt;br&gt;&lt;br&gt;&lt;br&gt;More details about the ICMHA 2006 can be found at:
&lt;br&gt;&lt;a href=&quot;http://www.iaeng.org/IMECS2006/ICMHA2006.html&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.iaeng.org/IMECS2006/ICMHA2006.html&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;ICMHA Conference Chair and Committee Members:
&lt;br&gt;&lt;br&gt;Prof. B. D. Aggarwala (Chair)
&lt;br&gt;Professor Emeritus
&lt;br&gt;Department of Mathematics and Statistics
&lt;br&gt;University of Calgary, Canada
&lt;br&gt;&lt;br&gt;Jiunn-Lin Wu
&lt;br&gt;Assistant Professor, Dept. of Computer Science,
&lt;br&gt;National Chung Hsing University, Taiwan
&lt;br&gt;&lt;br&gt;&lt;br&gt;********
&lt;br&gt;It will be highly appreciated if you can circulate these calls for
&lt;br&gt;papers to your colleagues.
&lt;br&gt;&lt;br&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=3302681&amp;i=1&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;&lt;br&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/CFP%3A-IAENG-International-Conference-on-Mathematical%2C-Statistical-and-Computer-Methods-in-HIV-AIDS-tp3302681p3302681.html" />
</entry>

<entry>
	<id>tag:old.nabble.com,2006:post-2570979</id>
	<title>Tissue transplant warning</title>
	<published>2006-01-24T20:50:19Z</published>
	<updated>2006-01-24T20:50:19Z</updated>
	<author>
		<name>kr0</name>
	</author>
	<content type="html">It looks like the FDA has issued a warning about donor tissue from
&lt;br&gt;Biomedical Tissue Services not meeting FDA standards. Apparently the tissue
&lt;br&gt;received since the beginning of 2004 may contain infectious diseases
&lt;br&gt;including HIV. If you go to
&lt;br&gt;&lt;a href=&quot;https://www.lawyersandsettlements.com/case/tissue_transplant&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;https://www.lawyersandsettlements.com/case/tissue_transplant&lt;/a&gt;&amp;nbsp;there is more
&lt;br&gt;information on this as well as what can be done about it. There is a free
&lt;br&gt;case evaluation provided for those who might have had tissue transplants. I
&lt;br&gt;hope that this may be of some help.
&lt;br&gt;&lt;br&gt;kr0
&lt;br&gt;&lt;br&gt;&lt;br&gt;_______________________________________________
&lt;br&gt;Hiv-biol mailing list
&lt;br&gt;&lt;a href=&quot;http://old.nabble.com/user/SendEmail.jtp?type=post&amp;post=2570979&amp;i=0&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;Hiv-biol@...&lt;/a&gt;
&lt;br&gt;&lt;a href=&quot;http://www.bio.net/biomail/listinfo/hiv-biol&quot; target=&quot;_top&quot; rel=&quot;nofollow&quot;&gt;http://www.bio.net/biomail/listinfo/hiv-biol&lt;/a&gt;&lt;br&gt;</content>
	<link rel="alternate" type="text/html" href="http://old.nabble.com/Tissue-transplant-warning-tp2570979p2570979.html" />
</entry>

</feed>
